Dyno Therapeutics
Dyno is at the forefront of AI and biotechnology, developing advanced genetic technologies aimed at revolutionizing next-generation medicine. Their innovative approach focuses on enhancing genetic agency for patients through high-performance gene delivery systems. By leveraging artificial intelligence, they are creating new methodologies for designing gene vectors, particularly targeting cell-specific capsid proteins derived from adeno-associated viruses (AAV), which are widely utilized in gene therapies. This positions Dyno as a leader in the biotech space, with a commitment to unlocking the full potential of genetic medicine.
Dyno Therapeutics
Dyno is at the forefront of AI and biotechnology, developing advanced genetic technologies aimed at revolutionizing next-generation medicine. Their innovative approach focuses on enhancing genetic agency for patients through high-performance gene delivery systems. By leveraging artificial intelligence, they are creating new methodologies for designing gene vectors, particularly targeting cell-specific capsid proteins derived from adeno-associated viruses (AAV), which are widely utilized in gene therapies. This positions Dyno as a leader in the biotech space, with a commitment to unlocking the full potential of genetic medicine.
